Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Deanol in minimal brain dysfunction.

J A Lewis, B S Lewis

Diseases of the Nervous System

|December 1, 1977

Summary

This summary is machine-generated.

Minimal brain dysfunction (MBD) remains controversial, with treatment claims lacking firm evidence. Further research is needed to clarify MBD

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gender differences in the effects of cardiovascular drugs.

European heart journal. Cardiovascular pharmacotherapy·2017

Same author

Cardiovascular pharmacotherapy.

International journal of cardiology·2016

Same author

Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.

Gene therapy·2015

Same author

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial.

Circulation·2015

Same author

Post placement positional atrial fibrillation and peripherally inserted central catheters.

Minerva anestesiologica·2009

Same author

Literature review and recommendations for clinical application of small-bowel capsule endoscopy, based on a panel discussion by international experts. Consensus statements for small-bowel capsule endoscopy, 2006/2007.

Endoscopy·2007

Same journal

Toxoplasmic encephalitis.

Diseases of the nervous system·2010

Same journal

Prevention of postconvulsive hyperexcitability in electro-shock therapy.

Diseases of the nervous system·2010

Same journal

The thematic apperception test.

Diseases of the nervous system·2010

Same journal

Care and treatment of the mentally ill in Illinois.

Diseases of the nervous system·2010

Same journal

Group psychotherapy in a convalescent hospital; organization and method.

Diseases of the nervous system·2010

Same journal

Disseminated sclerosis.

Diseases of the nervous system·2010

See all related articles

Area of Science:

Neuroscience
Pediatric Neurology
Psychopharmacology

Background:

The literature on minimal brain dysfunction (MBD) is characterized by confusion and controversy.
Claims regarding the existence and pharmacological treatment of MBD are often based on belief rather than established fact.
Some evidence suggests heterogeneity in arousal levels among patients with MBD.

Purpose of the Study:

To review the existing literature on minimal brain dysfunction (MBD).
To assess the current understanding and evidence for the role of deanol in MBD treatment.
To highlight methodological challenges in MBD research and treatment response assessment.

Main Methods:

Literature review of studies on minimal brain dysfunction and deanol.

Related Experiment Videos

Analysis of evidence regarding patient arousal levels and treatment efficacy.

Discussion of methodological issues in identifying appropriate patient populations and outcome measures.

Main Results:

The existence and treatment of MBD are subjects of ongoing debate and lack definitive scientific consensus.
Evidence suggests that some patients with MBD exhibit hypo-arousal, while others do not.
The efficacy of deanol for MBD remains unclear due to challenges in patient selection and response measurement.

Conclusions:

Despite controversies, there is sufficient preliminary evidence to warrant further investigation into deanol's effects on MBD.
Future research must address significant methodological problems to improve the reliability and validity of findings.
Clarifying patient arousal levels and response metrics is crucial for advancing MBD treatment research.